Recro Pharma, Inc.·4

May 31, 3:32 PM ET

Recro Pharma, Inc. 4

4 · Recro Pharma, Inc. · Filed May 31, 2016

Insider Transaction Report

Form 4
Period: 2016-05-26
McCallum Stewart
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2016-05-26$8.15/sh+1,000$8,1501,000 total
  • Purchase

    Common Stock

    2016-05-31$8.50/sh+250$2,1251,250 total

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT